These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 6446831)

  • 1. Plasma induced biotransformation of thymoxamine and its kinetics.
    Nielsen-Kudsk F; Jakobsen P; Magnussen I
    Acta Pharmacol Toxicol (Copenh); 1980 Jul; 47(1):11-6. PubMed ID: 6446831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolism of thymoxamine. II. Studies with 14C-thymoxamine in man.
    Vollmer KO; Poisson A
    Eur J Drug Metab Pharmacokinet; 1985; 10(1):71-6. PubMed ID: 3161739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolism of thymoxamine. III. Structure elucidation of the metabolites and interspecies comparison.
    Vollmer KO; von Hodenberg A
    Eur J Drug Metab Pharmacokinet; 1985; 10(2):139-45. PubMed ID: 2931278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antinoradrenergic activity of thymoxamine and its metabolites in rats.
    Roquebert J; Demichel P; Malek A
    Arch Int Pharmacodyn Ther; 1981 Jan; 249(1):12-25. PubMed ID: 6111983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolism of thymoxamine: identification of metabolites in rat.
    Feniou C; Neau B; Prat G; Cheze C; Fauran F; Roquebert J
    J Pharm Pharmacol; 1980 Feb; 32(2):104-7. PubMed ID: 6103028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microbial models of mammalian metabolism. Fungal metabolism of phenolic and nonphenolic p-cymene-related drugs and prodrugs. I. Metabolites of thymoxamine.
    Moussa C; Houziaux P; Danree B; Azerad R
    Drug Metab Dispos; 1997 Mar; 25(3):301-10. PubMed ID: 9172947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GLC method for the quantification of metabolites of thymoxamine in human plasma.
    Hengy H; Von Hodenberg A; Vollmer KO
    Eur J Drug Metab Pharmacokinet; 1985; 10(3):203-8. PubMed ID: 2935399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolism of 14C-thymoxamine in rat and man.
    Duchene P; Bernouillet C; Bromet-Petit M; Mosser J; Feniou C; Gaudin D; Virelizier H
    Xenobiotica; 1988 Aug; 18(8):919-28. PubMed ID: 2973182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolism of 14C-moxisylyte in hairless rat. Comparison between intravenous and oral route.
    Neau B; Roux J; Lambrey B; Courtiol C; Marty JP; Grislain L
    Arzneimittelforschung; 1995 Jan; 45(1):10-4. PubMed ID: 7893260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple-dose pharmacokinetics of moxisylyte after oral administration to healthy volunteers.
    Costa P; Bressolle F; Jarroux E; Sarrazin B; Mosser J; Navratil H; Galtier M
    J Pharm Sci; 1993 Sep; 82(9):968-71. PubMed ID: 8229699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism of thymoxamine. I. Studies with 14C-thymoxamine in rats.
    Vollmer KO; Liedtke B; Poisson A; von Hodenberg A; Steinbrecher W
    Eur J Drug Metab Pharmacokinet; 1985; 10(1):61-9. PubMed ID: 3161738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of thymoxamine on ouabain-induced arrhythmias in dogs.
    Oguro K; Hashimoto H; Nakashima M
    Tohoku J Exp Med; 1982 Aug; 137(4):361-8. PubMed ID: 6214872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro and in vivo alpha-blocking activity of thymoxamine and its two metabolites.
    Creuzet MH; Prat G; Malek A; Fauran F; Roquebert J
    J Pharm Pharmacol; 1980 Mar; 32(3):209-13. PubMed ID: 6103939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of thymoxamine in rabbits after ophthalmic and intravenous administration.
    Aldana I; González-Peñas E; Fos D; Bruseghini L; Esteras A; Ceppi Monti N; Gianesello V
    Eur J Drug Metab Pharmacokinet; 1994; 19(2):79-83. PubMed ID: 8001598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of thymoxamine on the human pupil.
    Lee DA; Rimele TJ; Brubaker RF; Nagataki S; Vanhoutte PM
    Exp Eye Res; 1983 May; 36(5):655-62. PubMed ID: 6221938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolism of 14C-moxisylyte after percutaneous application in hairless rat.
    Neau B; Roux J; Marty JP
    Arzneimittelforschung; 1998 Jan; 48(1):34-8. PubMed ID: 9522028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics study of 14C-moxisylyte after percutaneous application to hairless rat.
    Neau B; Roux J; Courtiol C; Lambrey B; Marty JP
    Arzneimittelforschung; 1995 Nov; 45(11):1161-5. PubMed ID: 8929231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of metabolites of thymoxamine in plasma by high performance liquid chromatography.
    Geahchan AE; Chambon PL
    Anal Chem; 1980 May; 52(6):999-1001. PubMed ID: 6446865
    [No Abstract]   [Full Text] [Related]  

  • 19. The gastroprokinetic and antiemetic drug metoclopramide is a substrate and inhibitor of cytochrome P450 2D6.
    Desta Z; Wu GM; Morocho AM; Flockhart DA
    Drug Metab Dispos; 2002 Mar; 30(3):336-43. PubMed ID: 11854155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of moxisylyte in healthy volunteers after intravenous and intracavernous administration.
    Costa P; Bressolle F; Sarrazin B; Mosser J; Galtier M
    J Pharm Sci; 1993 Jul; 82(7):729-33. PubMed ID: 8103112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.